Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: Determining Metabolic Effects of Valproate and Antipsychotic Therapy [NA]
A completed clinical trial investigated metabolic effects of valproate combined with antipsychotic therapy in schizophrenia; results posted …
-
FDA approval · 2020-02-06FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' supplemental abbreviated new drug application for aripiprazole, granting approval of a generic version.
-
FDA approval · 2020-02-05FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride submitted by Upsher-Smith Laboratories, LLC.
-
FDA approval · 2020-02-05FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for RISPERDAL CONSTA (risperidone) from Janssen Pharmaceuticals, Inc., signaling an approved mod…
-
FDA approval · 2020-02-05FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal M-Tab (risperidone) from Janssen Pharmaceuticals.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-02-05FDA Approved: RISPERDAL — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Risperdal (risperidone) from Janssen Pharmaceuticals, Inc. The action updates the product la…
-
FDA approval · 2020-02-05FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Chlorpromazine Hydrochloride from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2020-02-05FDA Approved: ARIPIPRAZOLE — Supplemental Application (Lannett Company, Inc.)
The FDA approves a supplemental application for ARIPIPRAZOLE (Aripiprazole) from Lannett Company, expanding approval of a generic antipsycho…
-
FDA approval · 2020-02-05FDA Approved: ARIPIPRAZOLE — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.’s supplemental application for aripiprazole (generic aripiprazole), authorizing the sale of a generic version of t…
-
FDA approval · 2020-02-05FDA Approved: ARIPIPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved Dr. Reddy's supplemental application to manufacture and market aripiprazole orally disintegrating tablets as a generic product.
-
FDA label_change · 2020-02-05FDA Approved: SEROQUEL — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for SEROQUEL (quetiapine) submitted by H2-Pharma, LLC, affecting the product labeling. The action re…
-
FDA approval · 2020-02-05FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride (Upsher-Smith Laboratories, LLC), confirming continued approval of …
-
FDA approval · 2020-02-05FDA Approved: ABILIFY MAINTENA — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
The FDA approved a supplemental application for ABILIFY MAINTENA (aripiprazole long-acting injectable) from Otsuka America Pharmaceutical, I…
-
FDA approval · 2020-02-05FDA Approved: PERSERIS — Supplemental Application (Indivior Inc.)
FDA approved a supplemental application for PERSERIS (risperidone) submitted by Indivior Inc.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: A Study of Lurasidone HCl in Subjects With Schizophrenia [Phase 4]
Phase 4 trial assessing lurasidone hydrochloride in adults with schizophrenia has completed.
-
FDA approval · 2020-02-05FDA Approved: CHLORPROMAZINE HCI — Supplemental Application (Dr. Reddy's Laboratories Inc.,)
FDA approved a supplemental application for chlorpromazine HCl from Dr. Reddy's Laboratories, confirming the generic product's approval unde…
-
FDA approval · 2020-02-05FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approves a supplemental application for a generic version of aripiprazole from Alembic Pharmaceuticals Inc.
-
FDA approval · 2020-02-04FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' supplemental application to market a generic ARIPIPRAZOLE under an ANDA.
-
FDA approval · 2020-02-04FDA Approved: ARIPIPRAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ARIPIPRAZOLE from Aurobindo Pharma Limited, indicating regulatory clearance for changes to the a…
-
CLINICAL_TRIALS trial_result · 2020-01-29Clinical Trial Update: Phase 2 Trial of a Nicotinic Agonist in Schizophrenia [Phase 2]
Phase 2 trial update for a nicotinic agonist in schizophrenia has completed with results posted.
-
FDA approval · 2020-01-27FDA Approved: ILOPERIDONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for iloperidone by Mylan Pharmaceuticals Inc., indicating a new or expanded approval for the gen…
-
FDA approval · 2020-01-27FDA Approved: QUETIAPINE EXTENDED RELEASE — Supplemental Application (ACI Healthcare USA, Inc.)
FDA approved a supplemental application for Quetiapine Extended Release, enabling the generic product by ACI Healthcare USA, Inc. to be mark…
-
FDA approval · 2020-01-23FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.
-
FDA approval · 2020-01-23FDA Approved: QUETIAPINE EXTENDED-RELEASE — Supplemental Application (AlignScience Pharma Inc.)
FDA approved AlignScience Pharma's supplemental ANDA for a quetiapine extended-release product, making a generic version of quetiapine exten…
-
FDA approval · 2020-01-17FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Original Application (Zydus Lifesciences Limited)
FDA approved Zydus Lifesciences Limited's original ANDA for chlorpromazine hydrochloride, a generic antipsychotic. The approval supports use…